Literature DB >> 29689263

Analysis of glycogen metabolic pathway utilization by dendritic cells and T cells using custom phenotype metabolic assays.

Phyu M Thwe1, Eyal Amiel2.   

Abstract

In the field of immunology, there is an increasing interest in cellular energy metabolism and its outcome on immune cell effector function. Activation of immune cells leads to rapid metabolic changes that are central to cellular biology in order to support the effector responses. Therefore, the need for user-friendly and dependable assay technologies to address metabolic regulation and nutrient utilization in immune cells is an important need in this field. Redox-dye reduction-based Phenotype MicroArray (PM) assays, which measure NADH reduction as a readout, developed by Biolog Inc., provide a wide screening of metabolites both in bacteria and mammalian cells. In this study, we delineate a detailed protocol of a customized Biolog assay for investigation of a specific metabolic pathway of interest. The option to be able to easily customize this technology offers researchers with a convenient assay platform to methodically examine specific nutrient substrates or metabolic pathways of interest in a rapid and cost effective manner.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biolog; Dendritic cells; Glucose; Glycogen; Metabolism; Phenotypic MicroArray

Mesh:

Substances:

Year:  2018        PMID: 29689263      PMCID: PMC5969523          DOI: 10.1016/j.jim.2018.04.006

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  11 in total

1.  The CD28 signaling pathway regulates glucose metabolism.

Authors:  Kenneth A Frauwirth; James L Riley; Marian H Harris; Richard V Parry; Jeffrey C Rathmell; David R Plas; Rebecca L Elstrom; Carl H June; Craig B Thompson
Journal:  Immunity       Date:  2002-06       Impact factor: 31.745

2.  Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells.

Authors:  Bart Everts; Eyal Amiel; Gerritje J W van der Windt; Tori C Freitas; Robert Chott; Kevin E Yarasheski; Erika L Pearce; Edward J Pearce
Journal:  Blood       Date:  2012-07-11       Impact factor: 22.113

3.  Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation.

Authors:  Connie M Krawczyk; Thomas Holowka; Jie Sun; Julianna Blagih; Eyal Amiel; Ralph J DeBerardinis; Justin R Cross; Euihye Jung; Craig B Thompson; Russell G Jones; Edward J Pearce
Journal:  Blood       Date:  2010-03-29       Impact factor: 22.113

4.  TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKɛ supports the anabolic demands of dendritic cell activation.

Authors:  Bart Everts; Eyal Amiel; Stanley Ching-Cheng Huang; Amber M Smith; Chih-Hao Chang; Wing Y Lam; Veronika Redmann; Tori C Freitas; Julianna Blagih; Gerritje J W van der Windt; Maxim N Artyomov; Russell G Jones; Erika L Pearce; Edward J Pearce
Journal:  Nat Immunol       Date:  2014-02-23       Impact factor: 25.606

5.  Cell-Intrinsic Glycogen Metabolism Supports Early Glycolytic Reprogramming Required for Dendritic Cell Immune Responses.

Authors:  Phyu M Thwe; Leonard R Pelgrom; Rachel Cooper; Saritha Beauchamp; Julie A Reisz; Angelo D'Alessandro; Bart Everts; Eyal Amiel
Journal:  Cell Metab       Date:  2017-09-05       Impact factor: 27.287

6.  The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function.

Authors:  Andrew N Macintyre; Valerie A Gerriets; Amanda G Nichols; Ryan D Michalek; Michael C Rudolph; Divino Deoliveira; Steven M Anderson; E Dale Abel; Benny J Chen; Laura P Hale; Jeffrey C Rathmell
Journal:  Cell Metab       Date:  2014-06-12       Impact factor: 27.287

Review 7.  Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival.

Authors:  Nancie J Maciver; Sarah R Jacobs; Heather L Wieman; Jessica A Wofford; Jonathan L Coloff; Jeffrey C Rathmell
Journal:  J Leukoc Biol       Date:  2008-06-24       Impact factor: 4.962

8.  Mechanistic target of rapamycin inhibition extends cellular lifespan in dendritic cells by preserving mitochondrial function.

Authors:  Eyal Amiel; Bart Everts; Daniel Fritz; Saritha Beauchamp; Burong Ge; Erika L Pearce; Edward J Pearce
Journal:  J Immunol       Date:  2014-08-08       Impact factor: 5.422

9.  Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype.

Authors:  Alex J Freemerman; Amy R Johnson; Gina N Sacks; J Justin Milner; Erin L Kirk; Melissa A Troester; Andrew N Macintyre; Pankuri Goraksha-Hicks; Jeffery C Rathmell; Liza Makowski
Journal:  J Biol Chem       Date:  2014-02-03       Impact factor: 5.157

10.  Assay of the multiple energy-producing pathways of mammalian cells.

Authors:  Barry R Bochner; Mark Siri; Richard H Huang; Shawn Noble; Xiang-He Lei; Paul A Clemons; Bridget K Wagner
Journal:  PLoS One       Date:  2011-03-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.